Dr. Mitchell Efros, MD
Claim this profileAccuMed Research Associates
Studies Transitional Cell Carcinoma
Studies Bladder Cancer
5 reported clinical trials
6 drugs studied
Area of expertise
1Transitional Cell Carcinoma
Stage II
Stage I
2Bladder Cancer
Stage II
Stage I
Affiliated Hospitals
Clinical Trials Mitchell Efros, MD is currently running
Cell-Based Therapy
for Stress Urinary Incontinence
This trial tests a new treatment for women who still have urine leakage after surgery. The treatment uses their own muscle cells, which are injected into the urinary passage to help strengthen it. The goal is to reduce accidental urine leakage during activities like laughing or coughing. Muscle-derived cells have been previously used in treatments for urinary incontinence, showing promise in improving urethral closure and reducing symptoms.
Recruiting1 award Phase 34 criteria
UGN-103
for Bladder Cancer
This Phase 3, single-arm, multicenter study will evaluate the efficacy and safety of UGN-103, a novel formulation of UGN-102, instilled in the urinary bladder of patients with low-grade non-muscle invasive bladder cancer (LG-NMIBC).
Recruiting2 awards Phase 32 criteria
More about Mitchell Efros, MD
Clinical Trial Related5 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Mitchell Efros, MD has experience with
- UGN-102
- AMDC-USR (iltamiocel)
- Placebo
- TURBT
- Viveve Treatment
- UGN-103
Breakdown of trials Mitchell Efros, MD has run
Transitional Cell Carcinoma
Bladder Cancer
Cancer
Urinary Incontinence
Stress Urinary Incontinence
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mitchell Efros, MD specialize in?
Mitchell Efros, MD focuses on Transitional Cell Carcinoma and Bladder Cancer. In particular, much of their work with Transitional Cell Carcinoma has involved Stage II patients, or patients who are Stage I.
Is Mitchell Efros, MD currently recruiting for clinical trials?
Yes, Mitchell Efros, MD is currently recruiting for 2 clinical trials in Garden City New York. If you're interested in participating, you should apply.
Are there any treatments that Mitchell Efros, MD has studied deeply?
Yes, Mitchell Efros, MD has studied treatments such as UGN-102, AMDC-USR (iltamiocel), Placebo.
What is the best way to schedule an appointment with Mitchell Efros, MD?
Apply for one of the trials that Mitchell Efros, MD is conducting.
What is the office address of Mitchell Efros, MD?
The office of Mitchell Efros, MD is located at: AccuMed Research Associates, Garden City, New York 11530 United States. This is the address for their practice at the AccuMed Research Associates.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.